285 related articles for article (PubMed ID: 18821637)
1. An efficient and scalable process for helper-dependent adenoviral vector production using polyethylenimine-adenofection.
Dormond E; Meneses-Acosta A; Jacob D; Durocher Y; Gilbert R; Perrier M; Kamen A
Biotechnol Bioeng; 2009 Feb; 102(3):800-10. PubMed ID: 18821637
[TBL] [Abstract][Full Text] [Related]
2. Identification of critical infection parameters to control helper-dependent adenoviral vector production.
Dormond E; Perrier M; Kamen A
J Biotechnol; 2009 Jun; 142(2):142-50. PubMed ID: 19501266
[TBL] [Abstract][Full Text] [Related]
3. Manufacturing of adenovirus vectors: production and purification of helper dependent adenovirus.
Dormond E; Kamen AA
Methods Mol Biol; 2011; 737():139-56. PubMed ID: 21590396
[TBL] [Abstract][Full Text] [Related]
4. Development of a suspension serum-free helper-dependent adenovirus production system and assessment of co-infection conditions.
Meneses-Acosta A; Dormond E; Jacob D; Tom R; Bernier A; Perret S; St-Laurent G; Durocher Y; Gilbert R; Kamen A
J Virol Methods; 2008 Mar; 148(1-2):106-14. PubMed ID: 18079009
[TBL] [Abstract][Full Text] [Related]
5. Development and optimization of an adenovirus production process.
Kamen A; Henry O
J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761
[TBL] [Abstract][Full Text] [Related]
6. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
[TBL] [Abstract][Full Text] [Related]
7. Scaleable production of adenoviral vectors by transfection of adherent PER.C6 cells.
Subramanian S; Kim JJ; Harding F; Altaras GM; Aunins JG; Zhou W
Biotechnol Prog; 2007; 23(5):1210-7. PubMed ID: 17715941
[TBL] [Abstract][Full Text] [Related]
8. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
[TBL] [Abstract][Full Text] [Related]
9. Development of a FLP/frt system for generating helper-dependent adenoviral vectors.
Ng P; Beauchamp C; Evelegh C; Parks R; Graham FL
Mol Ther; 2001 May; 3(5 Pt 1):809-15. PubMed ID: 11356086
[TBL] [Abstract][Full Text] [Related]
10. Scalable production of adeno-associated virus type 2 vectors via suspension transfection.
Park JY; Lim BP; Lee K; Kim YG; Jo EC
Biotechnol Bioeng; 2006 Jun; 94(3):416-30. PubMed ID: 16622883
[TBL] [Abstract][Full Text] [Related]
11. High-titer, serum-free production of adeno-associated virus vectors by polyethyleneimine-mediated plasmid transfection in mammalian suspension cells.
Hildinger M; Baldi L; Stettler M; Wurm FM
Biotechnol Lett; 2007 Nov; 29(11):1713-21. PubMed ID: 17636388
[TBL] [Abstract][Full Text] [Related]
12. Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination.
Umaña P; Gerdes CA; Stone D; Davis JR; Ward D; Castro MG; Lowenstein PR
Nat Biotechnol; 2001 Jun; 19(6):582-5. PubMed ID: 11385466
[TBL] [Abstract][Full Text] [Related]
13. Enhanced preparation of adeno-associated viral vectors by using high hydrostatic pressure to selectively inactivate helper adenovirus.
Leonard JN; Ferstl P; Delgado A; Schaffer DV
Biotechnol Bioeng; 2007 Aug; 97(5):1170-9. PubMed ID: 17252611
[TBL] [Abstract][Full Text] [Related]
14. Physical and infectious titers of helper-dependent adenoviral vectors: a method of direct comparison to the adenovirus reference material.
Palmer DJ; Ng P
Mol Ther; 2004 Oct; 10(4):792-8. PubMed ID: 15451463
[TBL] [Abstract][Full Text] [Related]
15. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus.
Cheshenko N; Krougliak N; Eisensmith RC; Krougliak VA
Gene Ther; 2001 Jun; 8(11):846-54. PubMed ID: 11423932
[TBL] [Abstract][Full Text] [Related]
16. Development and characterization of a cell line for large-scale, serum-free production of recombinant adeno-associated viral vectors.
Farson D; Harding TC; Tao L; Liu J; Powell S; Vimal V; Yendluri S; Koprivnikar K; Ho K; Twitty C; Husak P; Lin A; Snyder RO; Donahue BA
J Gene Med; 2004 Dec; 6(12):1369-81. PubMed ID: 15538729
[TBL] [Abstract][Full Text] [Related]
17. Quantitative comparison of polyethylenimine formulations and adenoviral vectors in terms of intracellular gene delivery processes.
Varga CM; Tedford NC; Thomas M; Klibanov AM; Griffith LG; Lauffenburger DA
Gene Ther; 2005 Jul; 12(13):1023-32. PubMed ID: 15815703
[TBL] [Abstract][Full Text] [Related]
18. [Producing recombinant adenovirus encoding green fluorescent protein (Ad-GFP) by suspension cultured HEK-293 N3S cells].
Tian B; Wu B; Zhang QW; Bi JJ; Wang L; Zhu BZ; Geng Y; Wu ZZ
Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):915-8. PubMed ID: 18051875
[TBL] [Abstract][Full Text] [Related]
19. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
[TBL] [Abstract][Full Text] [Related]
20. High-titer adenovirus vector production in 293S cell perfusion culture.
Cortin V; Thibault J; Jacob D; Garnier A
Biotechnol Prog; 2004; 20(3):858-63. PubMed ID: 15176892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
